TOTO, Throne, and Vivoo Launch AI Toilets Tracking Gut Health
The consumer health technology sector is experiencing rapid expansion in smart toilet innovations, driven by advancements in optical sensors, computer vision, and artificial intelligence. Since 2023, the category has evolved from basic bidets to comprehensive physiological tracking devices, responding to growing consumer interest in digestive wellness and rising colorectal cancer rates among younger demographics. Industry analysts project mass adoption within six to ten years as hardware shrinks and AI integration deepens. Several manufacturers have recently introduced competing systems. Throne Science, recently securing a $10 million Series A round, launched the Throne One, a $399 clip-on camera that analyzes stool consistency and urine color using clinician-trained AI. Japanese sanitation giant TOTO pioneered market entry with its Stool Scan feature embedded in premium Neorest models, available exclusively in Japan with a planned United States launch in early 2027. Additional entrants include Vivoo, focusing on urine hydration metrics, Kohler’s Dekoda sensor for blood and dehydration screening, and Withings’ U-Scan, which measures urinary biomarkers. These devices primarily operate through smartphone applications that log data and generate automated bowel movement diaries. Medical professionals recognize the operational value of continuous, objective health logging. Gastroenterologists note that automated tracking eliminates the recall biases inherent in traditional patient symptom journals, providing measurable baselines for treatment assessments. Throne’s integrated AI coach attempts to correlate dietary, stress, and sleep patterns with physiological output, though clinicians caution that current algorithms offer only generalized lifestyle recommendations. Experts emphasize that digestive health is influenced by complex variables, including microbiome composition and environmental factors, making precise causal analysis impossible without validated clinical research. While currently classified as wellness devices, the industry’s long-term objective is regulatory approval for clinical diagnostics. Throne Science envisions its technology serving as an early detection system for colorectal cancer through multispectral imaging. TOTO and other developers acknowledge that transitioning from consumer tracking to FDA-cleared medical diagnostics will require rigorous clinical validation. Researchers warn that distinguishing benign physiological variations from early disease markers remains scientifically premature, and unregulated health monitoring could potentially encourage unnecessary patient anxiety. The broader integration of toilet-based biometrics into healthcare infrastructure faces adoption hurdles similar to those seen with wearable fitness trackers. Physicians will need systematic frameworks to interpret continuous physiological streams, potentially blending automated data with clinical judgment. Industry observers note that toilets offer a unique advantage as mandatory daily interfaces, ensuring consistent data collection. As hardware costs decrease and software algorithms mature, smart toilet technology is poised to transition from novelty to a standard component of preventative health monitoring.
